©The Author(s) 2026.
World J Methodol. Mar 20, 2026; 16(1): 108875
Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.108875
Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.108875
Table 2 Donor blood and stool testing
| Blood testing |
| Complete blood count with differential |
| Blood sugar, renal and liver function tests |
| Hepatitis A, hepatitis B, hepatitis C and hepatitis E viruses |
| HIV-1 and HIV-2 |
| Cytomegalovirus and Epstein-Barr Virus serology |
| Treponema pallidum (syphilis) |
| Nematodes (Strongyloides stercoralis) |
| Stool testing |
| Clostridioides difficile |
| Common enteric pathogens, including Salmonella, Shigella, Campylobacter, Shiga toxin-producing Escherichia coli, Yersinia and Vibrio cholerae |
| Antimicrobial-resistant bacteria and antimicrobial resistance gene testing |
| Norovirus, rotavirus, adenovirus |
| Giardia lamblia, Cryptosporidium spp., Isospora, Cyclospora and Microsporidia |
| Protozoa and helminths/ova and parasites (including Entamoeba histolytica, Blastocystis hominis and Dientamoeba fragilis) |
| Helicobacter pylori faecal antigen (for upper route of FMT delivery) |
- Citation: Mundhra SK, Kochhar R. Methodological insights into fecal microbiota transplantation: Dissecting key approaches for success. World J Methodol 2026; 16(1): 108875
- URL: https://www.wjgnet.com/2222-0682/full/v16/i1/108875.htm
- DOI: https://dx.doi.org/10.5662/wjm.v16.i1.108875